The Clinical Problem Solvers

DECEMBER 16, 2020

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52

Clinic Education Clinical Practice Patient-Centered 52

FDA Law Blog

SEPTEMBER 20, 2021

When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.

Patient-Centered 52

Patient-Centered Manufacturing Clinic Provider 52

FDA Law Blog

JUNE 21, 2023

Cato — On June 1, CDRH announced that it is seeking public comment on questions regarding how CDRH can facilitate access to medical technologies designed for use outside of traditional clinical settings, particularly in the home. What medical technologies could be ideal to transition to use in non-clinical settings?

Medical 45

Medical Patients Healthcare Electronics 45

PEMBlog

SEPTEMBER 6, 2023

Laboratory evaluation should be based on individual patient history and exam. We need to choose wisely and act prudently for our patients, as individual practitioners and as accepting inpatient psychiatric facilities. Hosp Pediatr (2023) 13 (1): 66–71 2015;34(5):812-818 Chun TH. Ann Emerg Med. Ann Emerg Med. 2014;63(6):666-675.e663.

Lab Testing 52

Lab Testing Medical Patients Mental Health 52

FDA Law Blog

APRIL 23, 2023

This Draft Guidance focuses on the use of patient-level data from other clinical trials or from RWD sources. The Draft Guidance recommends that, where possible, the outcome should be assessed by individuals blinded to treatment status, which may require re-adjudication of externally controlled data.

Patient-Centered 49

Patient-Centered Clinic Patients Provider 49

FDA Law Blog

JUNE 27, 2024

After issuing an Order to Show Cause and Immediate Suspension of Registration in September 2022, and an administrative hearing in March 2023, DEA adopted the hearing Administrative Law Judge’s (“ALJ’s”) Recommended Decision to revoke Coconut Grove’s registration based on the public interest factors of 21 U.S.C. 21 C.F.R. §§ 1306.04(a),

Insurance 52

Insurance Patients Utilities Chronic Condition 52

Physician's Weekly

JUNE 22, 2025

High social risk burden in adults with IBD drives emergency care use and medication gaps—spotlighting the urgent need for social screening in clinical practice. A greater social risk burden was linked to increased odds of unplanned healthcare utilization (severe vs none: OR, 3.5 [1.2-10.2])

Healthcare 52

Healthcare Transportation IT Insurance 52

FDA Law Blog

JULY 9, 2024

Livornese — The Food and Drug Omnibus Reform Act (“FDORA”), enacted in December 2022, added a requirement that sponsors submit Diversity Action Plans (“DAPs”) for certain clinical studies involving drugs, biological products, or devices (codified at 21 U.S.C. § 355(z)(3) and 21 U.S.C. 360j(g)(9)(A)). intended use population.

Clinic 59

Clinic Provider Individual IT 59

PEMBlog

MARCH 27, 2024

She did her MD/PhD at Columbia University, where she investigated the diagnostic utility of exome sequencing for kidney disease. Updated 2023 Jul 17]. Meaning that an individual must inherit two copies of the mutation, so one from each of his or her parents, to be affected. References Jeanmonod R, Asuka E, Jeanmonod D.

Consulting 59

Consulting Individual Families Family 59

GeriPal

APRIL 6, 2023

Alex Practice-PC Program Information: UCSF’s Practice-PC program is now accepting applications for the 2023-2024 year. Okay, I don’t necessarily want to stay clinical, but I really love that spiritual work and what’s the closest profession. We randomized individual patients either to the SKY framework or to usual care.

IT 99

IT Patient-Centered Families Family 99

FDA Law Blog

JUNE 2, 2023

For 10 high-cost single source covered outpatient drugs selected annually by CMS, manufacturers would be required to respond to a so-called “price verification survey” by providing not only clinical and utilization information about the drug, but also costs of production, distribution, research, and marketing; revenue and profit; and ex-U.S.

Manufacturing 59

Manufacturing Vaccination Government Diagnosis 59

Annals of Family Medicine

NOVEMBER 20, 2024

Objective: This study aimed to investigate factors affecting insulin prescription patterns in individuals with T2DM. Study Design and Analysis: A cohort design using routine care data, we utilized Fine and Gray’s survival analysis to examine time-to-insulin initiation while accounting for death as a competing event.

Diabetes 130

Diabetes Primary Care Individual Management 130

GeriPal

DECEMBER 21, 2023

And that’s where, based on this, I made a decision to leave University of North Carolina to come to Indiana University because my mentor, Chris Callahan, just received the grant from AHRQ to build the first randomized clinical control trial that evaluated the comprehensive dementia care model. ” Diane: Fantastic. And guess what?

Patient-Centered 125

Patient-Centered IT Families Family 125

GeriPal

JULY 20, 2023

See the AAHPM Legislative Action Center [link] Write to the DEA, with guidance from AAHPM’s comments to the DEA March 2023. We were the highest utilizers of telemedicine in the whole UCSF health system at that time which we’re very proud of. Start with a story as Carly did in her Op Ed. Stories trump data. Eric: Yeah.

Telemedicine 73

Telemedicine Telehealth Patient-Centered Board-Certified 73